I-Mab Biopharma

I-Mab Biopharma is a US-based, global biotech company dedicated to developing and commercializing innovative immunotherapies for cancer treatment. Their mission is to deliver transformative medicines to patients through cutting-edge science and a focus on highly differentiated biologics. I-Mab has built a robust pipeline of products, including Uliledlimab (a CD73 antibody), Givastomig (a Claudin 18.2 x 4-1BB bispecific antibody), and Ragistomig (a PD-L1 x 4-1BB bispecific antibody), which are currently in various stages of clinical trials.

I-Mab is committed to addressing unmet needs in oncology by fine-tuning the immune network in cancer. Their innovative antibodies target specific pathways to enhance the body's natural defenses against tumors. The company has received recognition for its scientific advancements and its commitment to innovation, including awards such as "50 Smartest Companies" from MIT Technology Review and "Top 10 Immuno-Oncology Startups" from GEN. I-Mab's dedication to research and development, coupled with its strong global footprint, positions the company as a leader in the field of immuno-oncology.

I-Mab is a U.S.-based, global biotech company dedicated to developing and commercializing highly differentiated immunotherapies for the treatment of cancer. Their mission is to bring transformational medicines to patients through innovation, driven by their core values of innovation, integrity, and resilience.

I-Mab Biopharma fosters a culture of innovation, integrity, and resilience, emphasizing a commitment to bringing transformational therapies to patients worldwide. The company values its employees' contributions and encourages them to be passionate about their work, striving to make a positive impact on the lives of patients.

I-Mab is committed to fostering a diverse, equitable, and inclusive workplace, believing that a wide range of perspectives and experiences are crucial to its success. The company has a Board Diversity Policy, a Code of Business Conduct and Ethics, and a Diversity and Inclusion Policy in place, demonstrating its commitment to creating an environment where everyone feels valued, respected, and empowered to contribute their best.